tiprankstipranks
Advertisement

DBEU - ETF AI Analysis

Compare

Top Page

DBEU

Xtrackers MSCI Europe Hedged Equity ETF (DBEU)

Rating:63Neutral
Price Target:
DBEU, the Xtrackers MSCI Europe Hedged Equity ETF, earns a solid overall rating thanks to its sizable positions in financially strong companies like HSBC, Novartis, and AstraZeneca, which benefit from positive earnings outlooks, robust profitability, and strategic growth initiatives. At the same time, holdings such as Shell and Allianz introduce some drag through weaker technical trends and revenue or momentum challenges. The main risk factor is the fund’s concentration in European equities, which exposes investors to region-specific economic and regulatory conditions despite the currency hedging.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Leading European Blue-Chip Holdings
Top positions in well-known European companies like ASML, HSBC, Novartis, Nestlé, and Siemens have generally performed strongly, supporting the fund’s returns.
Broad Country and Sector Exposure
Holdings spread across major European markets and multiple sectors help reduce the impact of weakness in any single country or industry.
Negative Factors
Moderate Expense Ratio
The fund’s fees are not especially low, which means a noticeable portion of returns goes toward covering costs each year.
Concentration in a Few Markets
A large share of assets is focused in the UK, France, Germany, and Switzerland, increasing sensitivity to economic or political issues in those countries.
Mixed Performance Among Top Holdings
While several major positions are performing well, at least one key holding has been weak, which can drag on overall results if that continues.

DBEU vs. SPDR S&P 500 ETF (SPY)

DBEU Summary

DBEU is an ETF that follows the MSCI Europe U.S. Dollar Hedged Index, giving you broad exposure to large and mid-sized companies across many European countries while trying to reduce the impact of currency swings between the euro and the U.S. dollar. It holds well-known names like Nestlé and HSBC, along with many other banks, industrial firms, and healthcare companies. Someone might invest in DBEU to diversify beyond the U.S. and tap into Europe’s long-term growth while keeping currency risk lower. A key risk is that European stock prices can still rise or fall with overall market conditions.
How much will it cost me?The Xtrackers MSCI Europe Hedged Equity ETF (DBEU) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations.
What would affect this ETF?The DBEU ETF could benefit from positive economic growth in Europe, particularly in sectors like financials and industrials, which make up a significant portion of its holdings. Additionally, its currency hedging strategy provides protection against euro-to-dollar fluctuations, which can stabilize returns for U.S. investors. However, potential risks include economic slowdowns in Europe, regulatory changes affecting key industries, or geopolitical tensions that could impact the performance of its top holdings like ASML and Nestlé.

DBEU Top 10 Holdings

DBEU’s story is all about Europe’s heavy hitters doing most of the lifting. Chip-equipment giant ASML has been a key engine, rising over the past few months and giving the fund a strong tech tailwind, while HSBC, Shell, and Siemens add steady momentum from financials, energy, and industrials. On the flip side, defensives like Nestlé and pharma name AstraZeneca are losing a bit of steam, softening the overall ride. With broad sector exposure but a clear tilt toward European blue chips, the fund is firmly anchored in developed Europe, not the U.S.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV4.41%$33.47M€597.04B127.48%
76
Outperform
HSBC Holdings2.48%$18.78M£266.83B61.62%
80
Outperform
Roche Holding AG2.16%$16.41M$345.58B34.54%
73
Outperform
Novartis AG2.01%$15.24MCHF231.67B37.69%
80
Outperform
AstraZeneca1.81%$13.74M$261.19B19.44%
80
Outperform
Nestlé SA1.77%$13.41MCHF207.50B6.66%
71
Outperform
Shell (UK)1.71%$12.95M£183.16B21.96%
73
Outperform
Siemens1.61%$12.21M€207.53B21.64%
74
Outperform
Banco Santander1.40%$10.59M€175.79B59.08%
73
Outperform
Allianz1.30%$9.88M€161.74B25.58%
67
Neutral

DBEU Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
52.81
Positive
100DMA
51.26
Positive
200DMA
49.70
Positive
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 53.69, equal to the 50-day MA of 52.81, and equal to the 200-day MA of 49.70, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DBEU.

DBEU Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$765.91M0.45%
63
Neutral
$29.72B0.06%
61
Neutral
$9.40B0.50%
63
Neutral
$707.88M0.07%
63
Neutral
$118.51M0.25%
63
Neutral
$116.06M0.09%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
54.03
9.83
22.24%
VGK
Vanguard FTSE Europe ETF
EZU
iShares MSCI Eurozone ETF
SPEU
SPDR Portfolio Europe ETF
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
FLEE
Franklin FTSE Europe ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement